Italian Association of Myology 2023 (AIM)

Back

Robust Preclinical Data Support Development of DYNE-251 as a Potential Treatment for Individuals with DMD Mutations Amenable to Exon 51 Skipping (presentation)

View

Preclinical Data Support the Initiation of the ACHIEVE Trial of DYNE-101 in Individuals With Myotonic Dystrophy Type 1 (DM1) (poster)

View

©2026 Dyne Therapeutics, Inc. All rights reserved MED-00978. Date of preparation: July 2026.